Skip to main content
logo
Diamyd Medical AB (publ) (STO:DMYD.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.032
+0.002 (0.19%)
Jul 24, 2026, 5:29 PM CET

Diamyd Medical AB Revenue

Diamyd Medical AB had revenue of 949.00K SEK in the quarter ending May 31, 2026, a decrease of -28.70%. This brings the company's revenue in the last twelve months to 4.12M, down -25.25% year-over-year. In the fiscal year ending August 31, 2025, Diamyd Medical AB had annual revenue of 5.02M with 14.92% growth.

Revenue (ttm)
4.12M
Revenue Growth
-25.25%
P/S Ratio
369.52
Revenue / Employee
9.82K
Employees
44
Market Cap
159.63M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Aug 31, 20255.02M651.00K14.92%
Aug 31, 20244.36M617.00K16.47%
Aug 31, 20233.75M1.16M44.95%
Aug 31, 20222.59M2.14M482.21%
Aug 31, 2021444.00K-43.86M-99.00%
Aug 31, 202044.30M42.66M2,606.11%
Aug 31, 20191.64M818.00K99.88%
Aug 31, 2018819.00K-216.00K-20.87%
Aug 31, 20171.04M-8.00K-0.77%
Aug 31, 20161.04M-169.00K-13.94%
Aug 31, 20151.21M653.00K116.82%
Aug 31, 2014559.00K394.00K238.79%
Aug 31, 2013165.00K-1.44M-89.69%
Aug 31, 20121.60M--
Aug 31, 2011---
Aug 31, 2010---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
IRLAB Therapeutics AB92.46M
Xbrane Biopharma AB83.30M
Nanologica AB31.83M
Biovica International AB13.49M
Elicera Therapeutics AB10.64M
NextCell Pharma AB9.24M
Xintela AB2.59M
Simris Group AB (PUBL)1.88M
Revenue Rankings

Diamyd Medical AB News

More News